Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ

Iguratimod is known for its anti-inflammatory activities and therapeutic effects in patients with rheumatoid arthritis. It has previously been demonstrated that iguratimod attenuates bone destruction and osteoclast formation in the Walker 256 rat mammary gland carcinoma cell-induced bone cancer pain...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Med Rep
Main Authors: Wu, Ying-Xing, Sun, Yue, Ye, Ya-Ping, Zhang, Peng, Guo, Jia-Chao, Huang, Jun-Ming, Jing, Xing-Zhi, Xiang, Wei, Yu, Shi-Ying, Guo, Feng-Jing
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2017
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779905/
https://ncbi.nlm.nih.gov/pubmed/28983607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.7648
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares